Nucleic Acid Aptamers as Tools and Drugs: Recent Developments
- 26 September 2003
- journal article
- review article
- Published by Wiley in ChemBioChem
- Vol. 4 (10) , 963-971
- https://doi.org/10.1002/cbic.200300648
Abstract
Nucleic acid aptamers are molecules that bind to their ligands with high affinity and specificity. Unlike other functional nucleic acids such as antisense oligonucleotides, ribozymes, or siRNAs, aptamers almost never exert their effects on the genetic level. They manipulate their target molecules such as gene products or epitopes directly and site specifically, leaving nontargeted protein functions intact. In a similar way to antibodies, aptamers bind to many different kinds of target molecules with high specificity and can be made to order, but as a result of their different biochemical nature and size they can also be used complementary to antibodies. In some cases, aptamers might be more suitable or more specific than antibody approaches or small molecules, both as scientific and biotechnological tools and as therapeutic agents. Recent examples of characterization of aptamers as tools for scientific research to study regulatory circuits, as tools in diagnostic or biosensor development, and as therapeutic agents are discussed.Keywords
This publication has 88 references indexed in Scilit:
- A Viral RNA That Binds ATP and Contains a Motif Similar to an ATP-binding Aptamer from SELEXPublished by Elsevier ,2003
- Controlling Protein Activity with Ligand-Regulated RNA AptamersChemistry & Biology, 2002
- Structural characterization of a 2′F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120Biochemical and Biophysical Research Communications, 2002
- Protein detection using proximity-dependent DNA ligation assaysNature Biotechnology, 2002
- GnRH Binding RNA and DNA SpiegelmersChemistry & Biology, 2002
- Selection and Stabilization of the RNA Aptamers against the Human Immunodeficiency Virus Type-1 Nucleocapsid ProteinBiochemical and Biophysical Research Communications, 2002
- Archemix: drug discovery innovation based on evolutionary nucleic acid technology platformsDrug Discovery Today, 2002
- Selection of RNA Aptamers to the Alzheimer's Disease Amyloid PeptideBiochemical and Biophysical Research Communications, 2002
- Improvement of RNA Aptamer Activity against Myasthenic Autoantibodies by Extended Sequence SelectionBiochemical and Biophysical Research Communications, 2002
- Novel Approach to Specific Growth Factor Inhibition in VivoThe American Journal of Pathology, 1999